These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

8785 related articles for article (PubMed ID: 1667573)

  • 21. Expression and regulation of tumor suppressor gene maspin in breast cancer.
    Maass N; Nagasaki K; Ziebart M; Mundhenke C; Jonat W
    Clin Breast Cancer; 2002 Oct; 3(4):281-7. PubMed ID: 12425757
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activation of related transforming genes in mouse and human mammary carcinomas.
    Lane MA; Sainten A; Cooper GM
    Proc Natl Acad Sci U S A; 1981 Aug; 78(8):5185-9. PubMed ID: 6272293
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A working model for the time sequence of genetic changes in breast tumorigenesis.
    Singletary SE
    J Am Coll Surg; 2002 Feb; 194(2):202-16. PubMed ID: 11848636
    [No Abstract]   [Full Text] [Related]  

  • 24. nm23--relationship to the metastatic potential of breast carcinoma cell lines, primary human xenografts, and lymph node negative breast carcinoma patients.
    Russell RL; Geisinger KR; Mehta RR; White WL; Shelton B; Kute TE
    Cancer; 1997 Mar; 79(6):1158-65. PubMed ID: 9070493
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Endogenous MMTV in the normal mammary gland and in dimethylanthracene-induced mammary cancer in BALB/c mice].
    Komarova EA; Kriukova IN; Chernov MV; Kazarov AR
    Mol Gen Mikrobiol Virusol; 1987 Aug; (8):10-3. PubMed ID: 2825005
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative abilities of athymic nude mice and severe combined immune deficient (SCID) mice to accept transplants of induced rat mammary carcinomas: enhanced transplantation efficiency of those rat mammary carcinomas that have elevated expression of neu oncogene.
    Oakley CS; Welsch MA; Zhai YF; Chang CC; Gould MN; Welsch CW
    Int J Cancer; 1993 Apr; 53(6):1002-7. PubMed ID: 8097186
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The identification of metastasis-related gene products in a rodent mammary tumour model.
    Oates AJ; Barraclough R; Rudland PS
    Biochem Soc Trans; 1996 Aug; 24(3):353S. PubMed ID: 8878897
    [No Abstract]   [Full Text] [Related]  

  • 28. Modulation of tumor fatty acids, through overexpression or loss of thyroid hormone responsive protein spot 14 is associated with altered growth and metastasis.
    Wellberg EA; Rudolph MC; Lewis AS; Padilla-Just N; Jedlicka P; Anderson SM
    Breast Cancer Res; 2014 Dec; 16(6):481. PubMed ID: 25472762
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of the region(s) of human DNA responsible for metastasis in breast cancer.
    Chen HJ; Ke Y; Barraclough R; Rudland PS
    Biochem Soc Trans; 1996 Aug; 24(3):354S. PubMed ID: 8878898
    [No Abstract]   [Full Text] [Related]  

  • 30. Association of low nm23 RNA levels in human primary infiltrating ductal breast carcinomas with lymph node involvement and other histopathological indicators of high metastatic potential.
    Bevilacqua G; Sobel ME; Liotta LA; Steeg PS
    Cancer Res; 1989 Sep; 49(18):5185-90. PubMed ID: 2475243
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Elevation of breast carcinoma Nm23-H1 metastasis suppressor gene expression and reduced motility by DNA methylation inhibition.
    Hartsough MT; Clare SE; Mair M; Elkahloun AG; Sgroi D; Osborne CK; Clark G; Steeg PS
    Cancer Res; 2001 Mar; 61(5):2320-7. PubMed ID: 11280805
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Restriction endonuclease studies of hyperplastic outgrowth lines from BALB/cfC3H mouse hyperplastic mammary nodules.
    Cardiff RD; Fanning TG; Morris DW; Ashley RL; Faulkin LJ
    Cancer Res; 1981 Aug; 41(8):3024-9. PubMed ID: 6265073
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression level of the nm23 gene in clonal populations of metastatic murine and human neoplasms.
    Radinsky R; Weisberg HZ; Staroselsky AN; Fidler IJ
    Cancer Res; 1992 Oct; 52(20):5808-14. PubMed ID: 1394207
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Suppression of murine mammary carcinoma metastasis by the murine ortholog of breast cancer metastasis suppressor 1 (Brms1).
    Samant RS; Debies MT; Hurst DR; Moore BP; Shevde LA; Welch DR
    Cancer Lett; 2006 Apr; 235(2):260-5. PubMed ID: 15978719
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Host-mediated induction of tumor heterogeneity.
    Heppner GH; Chong YC; Fulton AM
    Ann N Y Acad Sci; 1989; 567():234-42. PubMed ID: 2552891
    [No Abstract]   [Full Text] [Related]  

  • 36. Cryolumpectomy for breast cancer: an experimental study.
    Rand RW; Rand RP; Eggerding FA; Field M; Denbesten L; King W; Camici S
    Cryobiology; 1985 Aug; 22(4):307-18. PubMed ID: 2992882
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of parity, tumor latency and transplantation on the activation of int loci in MMTV-induced, transplanted C3H mammary pre-neoplasias and their tumors.
    Schwartz MS; Smith GH; Medina D
    Int J Cancer; 1992 Jul; 51(5):805-11. PubMed ID: 1351886
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of c-myc on the progression of human breast cancer.
    Watson PH; Singh R; Hole AK
    Curr Top Microbiol Immunol; 1996; 213 ( Pt 2)():267-83. PubMed ID: 9053295
    [No Abstract]   [Full Text] [Related]  

  • 39. Induction of epithelial abnormalities that resemble human breast lesions by the expression of the neu/erbB-2 oncogene in reconstituted mouse mammary gland.
    Bradbury JM; Arno J; Edwards PA
    Oncogene; 1993 Jun; 8(6):1551-8. PubMed ID: 8099220
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of breast cancer with fibroblasts transfected with DNA from breast cancer cells.
    de Zoeten E; Carr-Brendel V; Markovic D; Taylor-Papadimitriou J; Cohen EP
    J Immunol; 1999 Jun; 162(11):6934-41. PubMed ID: 10352316
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 440.